Compare CASY & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CASY | IQV |
|---|---|---|
| Founded | 1959 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Diversified Commercial Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.0B | 28.6B |
| IPO Year | 1994 | 2013 |
| Metric | CASY | IQV |
|---|---|---|
| Price | $851.93 | $179.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $696.50 | $227.13 |
| AVG Volume (30 Days) | 590.7K | ★ 1.6M |
| Earning Date | 06-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | ★ 9.01 | 4.67 |
| EPS | ★ 14.79 | 1.61 |
| Revenue | ★ $15,940,899,000.00 | $9,739,000,000.00 |
| Revenue This Year | $9.54 | $6.77 |
| Revenue Next Year | $5.34 | $5.89 |
| P/E Ratio | ★ $57.90 | $109.73 |
| Revenue Growth | 7.25 | ★ 41.60 |
| 52 Week Low | $433.16 | $134.65 |
| 52 Week High | $867.56 | $247.05 |
| Indicator | CASY | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 73.43 | 60.32 |
| Support Level | $540.43 | $176.82 |
| Resistance Level | N/A | $181.95 |
| Average True Range (ATR) | 19.42 | 6.54 |
| MACD | 5.10 | 1.61 |
| Stochastic Oscillator | 86.39 | 87.20 |
Casey's General Stores Inc serves as convenience store chain with its 2,900 locations, positioned in the Midwest United States. About half of Casey's stores are located in rural towns with populations under 5,000. While fueling stations serve as a key traffic driver, about two-thirds of the company's gross profit stems from in-store sales of grocery items, prepared meals, and general merchandise. Casey's owns more than 90% of its stores and operates the majority of its warehousing and distribution processes internally.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.